ALKERMES | ALKS - Market Capitalization


ALKERMES reported $5.66B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 409.03B 81.15B Sep/2025
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
ALKERMES USD 4.95B 235M Sep/2025
Amgen USD 185.28B 33.35B Feb/2026
Biogen USD 20.54B 2.13B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Eli Lilly USD 722.15B 16.64B Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Malin Corporation EUR 150.45M 12.13M Jan/2026
Merck USD 294.09B 84.45B Feb/2026
Neurocrine Biosciences USD 13.92B 1.48B Sep/2025
Otsuka Holdings JPY 4.27T 384.44B Sep/2025
Pfizer USD 145.87B 10.78B Feb/2026
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Vertex Pharmaceuticals USD 100.41B 13.91B Sep/2025